close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Y-Prime, LLC

YPrime Launches Advanced eCOA Oversight to Strengthen Investigator Accountability and Participant Safety
From Y-Prime, LLC
Via GlobeNewswire
YPrime Releases Inaugural ESG Report, Reinforcing Commitment to Responsible Innovation in Clinical Research
From Y-Prime, LLC
Via GlobeNewswire
YPrime Named a Leader in Everest Group’s 2025 eCOA PEAK Matrix® Assessment
From Y-Prime, LLC
Via GlobeNewswire
YPrime Earns Prestigious EcoVadis Rating, Strengthening Commitment to Sustainable and Responsible Clinical Research
From Y-Prime, LLC
Via GlobeNewswire
YPrime Announces Advanced eCOA Localization Capabilities
From Y-Prime, LLC
Via GlobeNewswire
YPrime Releases Reimagined eCOA Automated Data Change Form for More Efficient Clinical Trial Data Management
From Y-Prime, LLC
Via GlobeNewswire
YPrime’s Karl McEvoy Appointed as eCOA Consortium Industry Co-Director for 2025
From Y-Prime, LLC
Via GlobeNewswire
YPrime Survey Finds 62% of Clinical Site Staff Report eCOA Platforms are Misaligned with Site Needs
From Y-Prime, LLC
Via GlobeNewswire
YPrime Recognized as Trailblazer in Patient Engagement by Everest Group
From Y-Prime, LLC
Via GlobeNewswire
YPrime Launches Breakthrough eCOA Platform to Deliver Up to 30% Faster Implementations
From Y-Prime, LLC
Via GlobeNewswire
YPrime Research Reveals User-Centric eCOA Technologies as Key to Overcoming Challenges in Endocrinology Clinical Trials
From Y-Prime, LLC
Via GlobeNewswire
YPrime Transforms Endocrinology and Autoimmune Trials through New Glucometer and eCOA Integrated Functionality
From Y-Prime, LLC
Via GlobeNewswire
YPrime Appoints Lindsay Daniel as Chief Human Resources Officer
From Y-Prime, LLC
Via GlobeNewswire
New YPrime Report Highlights eCOA's Impact on CNS Trials
From Y-Prime, LLC
Via GlobeNewswire
YPrime Launches Intuitive Tender Swollen Joint Count (TSJC) Assessment for Effortless eCOA
From Y-Prime, LLC
Via GlobeNewswire
YPrime Survey Reveals Challenges and Opportunities for Streamlining Oncology Trials with eCOA
From Y-Prime, LLC
Via GlobeNewswire
YPrime's Latest Research Reveals Significant Impact of eCOA Platform Delays on Clinical Trial Efficiency
From Y-Prime, LLC
Via GlobeNewswire
YPrime Unveils a Transformative Brand Focused on Solving for Certainty in Clinical Trials
From Y-Prime, LLC
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today